KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teladoc Health (TDOC) Other Non Operating Income (2020 - 2025)

Teladoc Health's Other Non Operating Income history spans 6 years, with the latest figure at $378000.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 105.15% year-over-year to $378000.0; the TTM value through Dec 2025 reached $10.4 million, up 271.81%, while the annual FY2025 figure was $10.4 million, 271.81% up from the prior year.
  • Other Non Operating Income for Q4 2025 was $378000.0 at Teladoc Health, up from -$815000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $8.4 million in Q2 2025 and bottomed at -$7.3 million in Q4 2024.
  • The 5-year median for Other Non Operating Income is -$288500.0 (2023), against an average of $197800.0.
  • The largest annual shift saw Other Non Operating Income plummeted 911.06% in 2022 before it skyrocketed 1586.86% in 2025.
  • A 5-year view of Other Non Operating Income shows it stood at -$405000.0 in 2021, then surged by 531.6% to $1.7 million in 2022, then decreased by 12.07% to $1.5 million in 2023, then crashed by 577.62% to -$7.3 million in 2024, then surged by 105.15% to $378000.0 in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Other Non Operating Income are $378000.0 (Q4 2025), -$815000.0 (Q3 2025), and $8.4 million (Q2 2025).